Gambaran Umum
NuGen Medical Devices Inc., based in Canada, operates primarily in the healthcare sector, focusing on the development and commercialization of innovative medical devices for insulin delivery. As part of its mission, NuGen is dedicated to enhancing the quality of life for patients managing diabetes through user-friendly device solutions. A key project for the company is the development of its proprietary needle-free injection technology, which aims to revolutionize the method of insulin delivery by offering a pain-free, efficient alternative to traditional needle syringes. This technology underscores NuGen's commitment to advancing diabetic care and improving patient compliance and comfort, propelling its standing in the medical devices market while aligning with ongoing trends towards minimally invasive medical treatments.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk NuGen Medical Devices Inc. per 2025 Jun 30 adalah 1.09 MM.
- Nilai operating income untuk NuGen Medical Devices Inc. per 2025 Jun 30 adalah -4.83 MM.
- Nilai net income untuk NuGen Medical Devices Inc. per 2025 Jun 30 adalah -3.21 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 1.09 | -4.83 | -3.21 |
2025-03-31 | 1.08 | -4.51 | -1.83 |
2024-12-31 | 1.01 | -5.16 | -5.23 |
2024-09-30 | 0.76 | -6.49 | -8.31 |
2024-06-30 | 0.35 | -6.45 | -7.63 |
2024-03-31 | 0.35 | -7.86 | -9.08 |
2023-12-31 | 0.33 | -8.05 | -9.36 |
2023-09-30 | 0.18 | -7.20 | -8.53 |
2023-06-30 | 0.07 | -5.86 | -7.18 |
2023-03-31 | 0.11 | -5.10 | -6.20 |
2022-12-31 | 0.15 | -4.79 | -5.58 |
2022-09-30 | 0.16 | -6.08 | -7.41 |
2022-06-30 | 0.18 | -6.59 | -7.79 |
2022-03-31 | 0.19 | -6.30 | -7.38 |
2021-12-31 | 0.14 | -5.79 | -7.11 |
2021-09-30 | 0.14 | -4.31 | -4.88 |
2021-06-30 | 0.13 | -3.77 | -5.00 |
2021-03-31 | 0.06 | -3.27 | -4.70 |
2020-12-31 | 0.05 | -2.59 | -3.67 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | -0.04 | -0.04 |
2024-06-30 | -0.04 | -0.04 |
2024-03-31 | -0.05 | -0.05 |
2023-12-31 | -0.06 | |
2023-09-30 | -0.06 | -0.06 |
2023-06-30 | -0.06 | -0.06 |
2023-03-31 | -0.06 | -0.06 |
2022-12-31 | -0.06 | |
2022-09-30 | -0.08 | -0.08 |
2022-06-30 | -0.10 | -0.10 |
2022-03-31 | -0.09 | -0.09 |
2021-12-31 | -0.10 | |
2021-09-30 | -0.08 | -0.08 |
2021-06-30 | -0.07 | -0.07 |
2021-03-31 | -0.08 | -0.08 |
2020-12-31 | -0.07 | -0.07 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk NuGen Medical Devices Inc. per 2025 Jun 30 adalah -5.22 MM.
- Nilai cash from investing activities untuk NuGen Medical Devices Inc. per 2025 Jun 30 adalah -0.06 MM.
- Nilai kas dari aktivitas pendanaan untuk NuGen Medical Devices Inc. per 2025 Jun 30 adalah 10.53 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -5.22 | -0.06 | 10.53 |
2025-03-31 | -4.72 | -0.01 | 10.52 |
2024-12-31 | -4.71 | -0.01 | 11.21 |
2024-09-30 | -3.17 | -0.00 | 10.85 |
2024-06-30 | -3.19 | -0.05 | 2.11 |
2024-03-31 | -5.48 | -0.05 | 5.48 |
2023-12-31 | -6.71 | -0.05 | 7.10 |
2023-09-30 | -5.62 | -0.05 | 7.14 |
2023-06-30 | -5.06 | -0.00 | 6.32 |
2023-03-31 | -3.10 | -0.00 | 2.95 |
2022-12-31 | -2.13 | -0.00 | 0.51 |
2022-09-30 | -4.64 | 0.00 | 4.64 |
2022-06-30 | -4.80 | 0.00 | 4.72 |
2022-03-31 | -4.64 | 0.00 | 4.81 |
2021-12-31 | -4.10 | 0.00 | 5.58 |
2021-09-30 | -1.97 | 0.00 | 1.95 |
2021-06-30 | -1.89 | -0.01 | 1.72 |
2021-03-31 | -1.77 | 0.05 | 2.07 |
2020-12-31 | -1.39 | 0.05 | 1.62 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 |
Efektivitas Manajemen
- roa untuk NuGen Medical Devices Inc. pada 2025 Jun 30 adalah -0.30.
- roic untuk NuGen Medical Devices Inc. pada 2025 Jun 30 adalah -0.16.
- croic untuk NuGen Medical Devices Inc. pada 2025 Jun 30 adalah 0.50.
- ocroic untuk NuGen Medical Devices Inc. pada 2025 Jun 30 adalah -0.41.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.30 | -0.16 | 0.50 | -0.41 | |
2025-03-31 | -1.32 | -0.66 | 0.61 | -0.25 | |
2024-12-31 | -1.20 | -0.66 | 0.61 | -0.25 | |
2024-09-30 | -0.90 | -1.69 | -0.24 | -0.70 | |
2024-06-30 | |||||
2024-03-31 | |||||
2023-12-31 | |||||
2023-09-30 | -9.45 | 1.55 | |||
2023-06-30 | |||||
2023-03-31 | -8.19 | ||||
2022-12-31 | |||||
2022-09-30 | |||||
2022-06-30 | |||||
2022-03-31 | |||||
2021-12-31 | -0.49 | -0.95 | 0.20 | -0.54 | |
2021-09-30 | -0.85 | -0.01 | -0.34 | ||
2021-06-30 | -9.27 | -1.50 | -0.06 | -0.57 | |
2021-03-31 | -8.72 | -1.07 | 0.07 | -0.40 | |
2020-12-31 | -6.81 | -0.73 | 0.05 | -0.28 |
Gross Margins
- marjin kotor untuk NuGen Medical Devices Inc. pada 2025 Jun 30 adalah 0.52.
- marjin bersih untuk NuGen Medical Devices Inc. pada 2025 Jun 30 adalah -1.70.
- marjin operasi untuk NuGen Medical Devices Inc. pada 2025 Jun 30 adalah -4.18.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.52 | -1.70 | -4.18 |
2025-03-31 | 0.47 | -10.89 | -8.50 |
2024-12-31 | 0.47 | -10.89 | -8.50 |
2024-09-30 | 0.49 | -22.01 | -18.60 |
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | -98.41 | -80.37 | |
2023-06-30 | -98.41 | -80.37 | |
2023-03-31 | -56.78 | -46.70 | |
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | -32.58 | 0.00 | |
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | 0.86 | -38.85 | -29.33 |
2021-03-31 | 0.71 | -74.48 | -50.90 |
2020-12-31 | 0.73 | -77.61 | -54.76 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) |